Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription

Articles published in Br J Cancer

Retrieve available abstracts of 9 articles:
HTML format

Single Articles

    May 2022
  1. NOBLE RA, Thomas H, Zhao Y, Herendi L, et al
    Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma.
    Br J Cancer. 2022 May 26. pii: 10.1038/s41416-022-01848.
    PubMed     Abstract available

    November 2021
  2. AITAMER M, Akil H, Vignoles C, Branchaud M, et al
    CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles.
    Br J Cancer. 2021 Nov 6. pii: 10.1038/s41416-021-01611.
    PubMed     Abstract available

    October 2021
  3. DURAND-PANTEIX S, Monteil J, Sage M, Garot A, et al
    Preclinical study of (212)Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01585.
    PubMed     Abstract available

  4. HOUNSOME L, Eyre TA, Ireland R, Hodson A, et al
    Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England.
    Br J Cancer. 2021 Oct 5. pii: 10.1038/s41416-021-01525.
    PubMed     Abstract available

    August 2021
  5. SMITH MJ, Fernandez MAL, Belot A, Quartagno M, et al
    Investigating the inequalities in route to diagnosis amongst patients with diffuse large B-cell or follicular lymphoma in England.
    Br J Cancer. 2021 Aug 13. pii: 10.1038/s41416-021-01523.
    PubMed     Abstract available

    May 2021
  6. CAI J, Tian X, Ma S, Zhong L, et al
    A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
    Br J Cancer. 2021 May 19. pii: 10.1038/s41416-021-01434.
    PubMed     Abstract available

    December 2020
  7. HERZOG LO, Walters B, Buono R, Lee JS, et al
    Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax.
    Br J Cancer. 2020 Dec 14. pii: 10.1038/s41416-020-01205.
    PubMed     Abstract available

  8. SHAPIRO GI, LoRusso P, Dowlati A, T Do K, et al
    A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma.
    Br J Cancer. 2020 Dec 14. pii: 10.1038/s41416-020-01180.
    PubMed     Abstract available

  9. AMERATUNGA M, Brana I, Bono P, Postel-Vinay S, et al
    First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
    Br J Cancer. 2020;123:1730-1736.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.